Basket

  1. 1.
    0523540 - ÚMCH 2021 RIV GB eng J - Journal Article
    Dölen, Y. - Valente, M. - Tagit, O. - Jäger, Eliezer - van Dinther, E. A. W. - van Riessen, N. K. - Hrubý, Martin - Gileadi, U. - Cerundolo, V. - Figdor, C. G.
    Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses.
    Oncoimmunology. Roč. 9, č. 1 (2020), s. 1-14, č. článku 1738813. ISSN 2162-402X. E-ISSN 2162-402X
    R&D Projects: GA ČR(CZ) GA17-07164S
    EU Projects: European Commission(XE) 686089 - PRECIOUS
    Institutional support: RVO:61389013
    Keywords : cancer vaccines * nanoparticle biodistribution * iNKT cells
    OECD category: Polymer science
    Impact factor: 8.110, year: 2020
    Method of publishing: Open access
    https://www.tandfonline.com/doi/full/10.1080/2162402X.2020.1738813
    Permanent Link: http://hdl.handle.net/11104/0308171
     
     

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.